Astal Laboratories Ltd

AI
Astal Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Astal Laboratories Ltd

₹ 63.8 -5.95%
23 Oct - close price
astallabs.com BSE: 512600
About

Astal Laboratories Ltd is engaged in Manufacturing and Trading of all kinds of active Pharmaceutical Ingredients (Bulk Drugs).[1]

Key Points

Business Update[1]
Astal Laboratories Limited (formerly Macro International Limited) was taken over in 2022 under SEBI takeover regulations, following which its objects were changed to manufacturing and sale of pharmaceutical intermediates and bulk drugs. The name was subsequently changed to Astal Laboratories Limited in May 2024.

Website BSE
  • Market Cap ₹ 279 Cr.
  • Current Price ₹ 63.8
  • High / Low ₹ 102 / 60.4
  • Stock P/E 19.0
  • Book Value ₹ 79.1
  • Dividend Yield 0.00 %
  • ROCE 9.15 %
  • ROE 7.96 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.81 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 4.59%
  • Company has high debtors of 229 days.
  • Promoter holding has decreased over last 3 years: -51.1%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Dec 2025 Mar 2026 Jun 2026
23.47 52.24 134.05 100.94
19.29 48.69 123.86 88.69
Operating Profit 4.18 3.55 10.19 12.25
OPM % 17.81% 6.80% 7.60% 12.14%
0.04 0.04 0.10 0.14
Interest 0.27 0.33 1.09 1.18
Depreciation 0.10 0.12 0.86 0.86
Profit before tax 3.85 3.14 8.34 10.35
Tax % 28.57% 24.52% 7.91% 8.99%
2.74 2.36 7.68 9.42
EPS in Rs 2.79 2.19 1.82 2.15
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
64 250
51 229
Operating Profit 13 21
OPM % 20% 8%
0 0
Interest 1 2
Depreciation 0 1
Profit before tax 12 18
Tax % 25% 17%
9 15
EPS in Rs 9.08 3.48
Dividend Payout % 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 289%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 65%
Stock Price CAGR
10 Years: 12%
5 Years: 44%
3 Years: 24%
1 Year: -36%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 10 42
Reserves 26 292
13 49
14 136
Total Liabilities 63 519
11 64
CWIP 0 0
Investments 0 203
52 251
Total Assets 63 519

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
-13 -18
-8 -2
3 3
Net Cash Flow -17 -17
Free Cash Flow -18 -19
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -96% -80%

Ratios

Consolidated / View Standalone

Mar 2025 Mar 2026
Debtor Days 157 229
Inventory Days 112 112
Days Payable 82 206
Cash Conversion Cycle 187 135
Working Capital Days 97 113
ROCE % 9%

Insights

In beta
Mar 2024 Mar 2025 Mar 2026
Domestic share of revenue
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Intermediates share of revenue
% ・Standalone data
Number of permanent employees
count ・Standalone data
Third-party manufacturing active
0/1 (binary) ・Standalone data
Own plant manufacturing active
0/1 (binary) ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
39.79% 19.93% 19.93% 19.93% 19.93% 19.93% 19.93% 18.19% 18.19% 4.70% 4.53% 4.59%
60.21% 80.07% 80.07% 80.07% 80.07% 80.07% 80.08% 81.81% 81.79% 95.29% 95.46% 95.40%
No. of Shareholders 1,1851,2411,2421,6291,9252,3022,7212,8992,9263,0653,2743,351

Documents

Announcements

Annual reports